Jean F. Voltaire

Array ( [id] => 6134405 [patent_doc_number] => 20110008307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Cephalotaxine Alkaloid Compositions and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/761251 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4157 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008307.pdf [firstpage_image] =>[orig_patent_app_number] => 12761251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4281 [patent_doc_number] => 07816323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-19 [patent_title] => 'Methods of using corticotropin-releasing factor for the use of the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/758621 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16214 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/816/07816323.pdf [firstpage_image] =>[orig_patent_app_number] => 12758621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6523135 [patent_doc_number] => 20100262115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'NANOPARTICLES FOR CANCER SONODYNAMIC AND PHOTODYNAMIC THERAPY' [patent_app_type] => utility [patent_app_number] => 12/755942 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7927 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20100262115.pdf [firstpage_image] =>[orig_patent_app_number] => 12755942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6466776 [patent_doc_number] => 20100190800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'COMBINATON OF PYRIMIDYLAMINOBENZAMIDE COMPOUNDS AND IMATINIB FOR TREATING OR PREVENTING PROLIFERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/753184 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6390 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190800.pdf [firstpage_image] =>[orig_patent_app_number] => 12753184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138759 [patent_doc_number] => 20120093917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'METNASE AND INTNASE INHIBITORS AND THEIR USE IN TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/255708 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 23045 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070252 [patent_doc_number] => 20110045102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Cancer chemotherapy compositions comprising PI3K pathway modulators and triptolide' [patent_app_type] => utility [patent_app_number] => 12/661654 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21292 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045102.pdf [firstpage_image] =>[orig_patent_app_number] => 12661654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53421 [patent_doc_number] => 07772274 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-08-10 [patent_title] => 'Docetaxel formulations with lipoic acid' [patent_app_type] => utility [patent_app_number] => 12/721563 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13880 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772274.pdf [firstpage_image] =>[orig_patent_app_number] => 12721563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239921 [patent_doc_number] => 20120148661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'HIGH BIOAVAILABILITY ORAL PICOPLATIN ANTI-CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 13/264343 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19127 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13264343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039532 [patent_doc_number] => 20110092581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Docetaxel Formulations with Lipoic Acid' [patent_app_type] => utility [patent_app_number] => 12/721564 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13880 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092581.pdf [firstpage_image] =>[orig_patent_app_number] => 12721564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231927 [patent_doc_number] => 20100184807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Methods to inhibit tumor cell growth by using proton pump inhibitors' [patent_app_type] => utility [patent_app_number] => 12/661084 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 7401 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184807.pdf [firstpage_image] =>[orig_patent_app_number] => 12661084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6295387 [patent_doc_number] => 20100160257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'USE OF HDAC INHIBITORS FOR THE TREATMENT OF MYELOMA' [patent_app_type] => utility [patent_app_number] => 12/717373 [patent_app_country] => US [patent_app_date] => 2010-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8464 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160257.pdf [firstpage_image] =>[orig_patent_app_number] => 12717373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262253 [patent_doc_number] => 20100297075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'COMBINATIONAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/704361 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 51234 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297075.pdf [firstpage_image] =>[orig_patent_app_number] => 12704361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6602654 [patent_doc_number] => 20100323002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'INHIBITION OF MELANOGENESIS AND MELANOMA METASTASIS WITH P-AMINO BENZOIC ACID (PABA)' [patent_app_type] => utility [patent_app_number] => 12/701093 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8586 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323002.pdf [firstpage_image] =>[orig_patent_app_number] => 12701093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8212079 [patent_doc_number] => 20120130144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'TREATMENT OF LUNG CANCER WITH A NITROBENZAMIDE COMPOUND IN COMBINATION WITH A GROWTH FACTOR INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/146865 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 35745 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20120130144.pdf [firstpage_image] =>[orig_patent_app_number] => 13146865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6645138 [patent_doc_number] => 20100227906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'C-substituted Diindolylmethane Compositions and Methods for the Treatment of Multiple Cancers' [patent_app_type] => utility [patent_app_number] => 12/698437 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8223 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227906.pdf [firstpage_image] =>[orig_patent_app_number] => 12698437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221319 [patent_doc_number] => 20120135522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'METHODS OF MODULATING CELL REGULATION BY INHIBITING P53' [patent_app_type] => utility [patent_app_number] => 13/378623 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7035 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712053 [patent_doc_number] => 20120004262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE' [patent_app_type] => utility [patent_app_number] => 13/138143 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45895 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13138143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231899 [patent_doc_number] => 20100184801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'FUSED AMINO PYRIDINES FOR THE TREATMENT OF BRAIN TUMORS' [patent_app_type] => utility [patent_app_number] => 12/688312 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 20497 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184801.pdf [firstpage_image] =>[orig_patent_app_number] => 12688312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446388 [patent_doc_number] => 08288440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Formulations of suberoylanilide hydroxamic acid and methods for producing same' [patent_app_type] => utility [patent_app_number] => 12/686812 [patent_app_country] => US [patent_app_date] => 2010-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26566 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12686812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323489 [patent_doc_number] => 20100113829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'FORMULATIONS OF SUBEROYLANILIDE HYDROXAMIC ACID AND METHODS FOR PRODUCING SAME' [patent_app_type] => utility [patent_app_number] => 12/686830 [patent_app_country] => US [patent_app_date] => 2010-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26475 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113829.pdf [firstpage_image] =>[orig_patent_app_number] => 12686830 [rel_patent_id] =>[rel_patent_doc_number] =>)